You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 4, July 26, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (24)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Alert me on articles by topic

Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation

Gregor Hron, MD; Marietta Kollars; Bernd R. Binder, MD; Sabine Eichinger, MD; Paul A. Kyrle, MD

JAMA. 2006;296:397-402.

Context  Screening of patients with venous thromboembolism (VTE) for thrombophilic risk factors is common clinical practice. Because of the large number of risk factors, assessing the risk of recurrence in an individual patient is complex. A method covering multicausal thrombophilia is therefore required.

Objective  To investigate the relationship between recurrence of VTE and a simple global coagulation assay measuring thrombin generation.

Design, Setting, and Participants  Prospective cohort study of 914 patients with first spontaneous VTE who were followed up for an average of 47 months after discontinuation of vitamin K antagonist therapy. The study was conducted at the Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria, between July 1992 and July 2005. Thrombin generation was measured by a commercially available assay system. Patients with a previous or secondary VTE; antithrombin, protein C, or protein S deficiencies; presence of lupus anticoagulant; cancer; or pregnancy were excluded.

Main Outcome Measure  Objectively documented symptomatic recurrent VTE.

Results  Venous thromboembolism recurred in 100 patients (11%). Patients without recurrent VTE had lower thrombin generation than patients with recurrence (mean [SD], 349.2 [108.0] nM vs 419.5 [110.5] nM, respectively; P<.001). Compared with patients who had thrombin generation greater than 400 nM, the relative risk (RR) of recurrence was 0.42 (95% confidence interval [CI], 0.26-0.67; P<.001) in patients with values between 400 nM and 300 nM; for patients with lower values, the RR was 0.37 (95% CI, 0.21-0.66; P = .001). After 4 years, the probability of recurrence was 6.5% (95% CI, 4.0%-8.9%) among patients with thrombin generation less than 400 nM compared with 20.0% (95% CI, 14.9%-25.1%) among patients with higher values (P<.001). Patients with thrombin generation less than 400 nM, representing two thirds of patients, had a 60% lower RR of recurrence than those with greater values (RR, 0.40; 95% CI, 0.27-0.60; P<.001).

Conclusion  Measurement of thrombin generation identifies patients at low risk for recurrent VTE.


Author Affiliations: Departments of Internal Medicine I (Drs Hron, Eichinger, and Kyrle and Ms Kollars) and Vascular Biology and Thrombosis Research, Center for Biomolecular Medicine and Pharmacology (Dr Binder), Medical University of Vienna, Austria.


RELATED ARTICLE

Thrombophlebitis
Janet M. Torpy, Alison E. Burke, and Richard M. Glass
JAMA. 2006;296(4):468.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thrombin-generating capacity in patients with von Willebrand's disease
Rugeri et al.
haematol 2007;92:1639-1646.
ABSTRACT | FULL TEXT  

Update in Hematology
DeLoughery
ANN INTERN MED 2007;147:717-724.
FULL TEXT  

Risk of recurrence after a first venous thromboembolic event in young women
Laczkovics et al.
haematol 2007;92:1201-1207.
ABSTRACT | FULL TEXT  

Sophia
Cattermole and Wyatt
Emerg. Med. J. 2006;23:890-890.
FULL TEXT  

What's new in the other general journals.
Tonks
BMJ 2006;333:295-296.
FULL TEXT  

New Approach to Identifying VTE Patients at Risk for Recurrence
JWatch General 2006;2006:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.